When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by:Brian C. Barnes and Sophia F. Zahn
OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION]
Before Chen, Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas.
Summary: A verdict form that asks a single question as to whether the defendant infringed any asserted claim is improper because it does not ensure a unanimous jury finding of infringement as to each asserted patent.
Ollnova sued ecobee for infringement of four patents relating to wireless communications systems. The district court’s verdict form included only a single infringement question covering all asserted patents:
“Did Ollnova, the Plaintiff, prove by a preponderance of the evidence that ecobee, the Defendant, infringed ANY of the Asserted Claims of the Asserted Patents?”
The jury returned a verdict answering Yes to the infringement question, but it did not identify which patent or patents were infringed. ecobee moved for a new trial, arguing the verdict form improperly allowed the jury to find liability without a unanimous finding that ecobee infringed any particular claim of any patent. The district court denied ecobee’s motion, and ecobee appealed.
The Federal Circuit reversed, holding that the verdict form created a substantial risk that the verdict did not reflect unanimous agreement as to any particular patent. Because the verdict form asked a single infringement question encompassing multiple patents, it required a “Yes” answer even if individual jurors believed that different patents were infringed without unanimous agreement on any one patent. The Federal Circuit explained that because a patent infringement verdict must be unanimous as to each asserted patent, the verdict form “needed to have included … separate infringement questions for each asserted patent” to ensure unanimity. Accordingly, the Federal Circuit vacated the infringement judgment and the associated damages award and remanded for a new trial on infringement and damages.
Editor: Sean Murray
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
Reap What You Sow Industry Specific Applications of Data Processing Do Not Survive 101
AGI SURETRACK LLC v. FARMERS EDGE INC. Before Moore, Mayer , and Lourie. Appeal from the District of Nebraska. Summary : Patents claiming data collection, processing, and transmission using generic computer components are patent-ineligible abstract ideas…